OR, they have something to say ....if I were you I would bet everything you can get your hands on against the house...bye, bye. axxholes
Are patient testimony and care giver testimony also cherry picked?
I do not like doing business with liars. If he has to be a liar to compete then we are all screwed. We buy based on what we are told, DD and research. We own that decision, no problem. Being told lies which directly influence decisions cannot be tolerated. He has miracles to perform and lots of splaining to do, and even then he has lost credibility forever. All the claims about world class BOD(team) BD assays, way back from the start are just BS.
"Stock trades at only 65 cents a pop. Target market is multi billion dollar, and everyone is interested in getting in on the game. Theoretically, Anavex is one of the most promising drugs, targeting the hypothesized root cause of all amylo-degenerative diseases, including AD. If they can take the drug just through a phase 2, which isn't unlikely since they did so well with phase 2a, they will be bought off for more than a billion dollars. The only hurdle - apart from the medical aspect, which I think is promising - is the patent. That is a non-issue as long as Dr Vamvakides asks for a reasonable amount of money, or the issue is otherwise resolved. Bottomline, there is a lot of promise and I am buying as much as I can. I will sell a bunch on the recent spike to recover costs, but hold the bulk for the long haul.
"Data has been published in peer-reviewed publications on LymPro with 160 patients, demonstrating 92% co-positivity and 91% co-negativity with an overall 95% accuracy rating for LymPro.
New Exploratory Alzheimer’s Drug ANAVEX 2-73 Changes in Electrophysiological Markers in Alzheimer’s Disease - First Patient Data from an ongoing Phase 2a Study in mild-to-moderate Alzheimer’s Patients
Date/Time:9:30 a.m. - 4:15 p.m.
Wed., July 22, 2015
Let's hope this is real.
9:30 a.m. - 4:15 p.m.
E. Washington Convention Center, Hall E
Back in the day, breakthroughs were identifed by this kind of result. Unless we are being lied to, these results suggest real change.
There is something very wrong here. The SP just continues to drop, no responses from management. What are holders expected to do?To think?
NOTED..."InVivo’s management will be displaying and explaining intraoperative videos from the first two subjects enrolled in the trial thus far. In addition, intraoperative videos evaluating surgical implantation of the investigational Neuro-Spinal Scaffold in a porcine model of acute spinal cord injury at various early time points will be presented."
Key words...video and two..
Hope your instincts are right. For me MANF opens the door to the process of understanding those things that we know we do not know. The universe of unknown links which trigger flaws in some humans and not in others. I honestly felt that LYMPRO would have started a new discovery-understanding-science process in AZ by now.Since learning occurs at the fring of knowledge. LYMPRO science presents a linked site for spontaneous learning where meaningful criteria for defining AZ can occur.
Gerald Commissiong @G_Commish
@RSVPRealty We will be making an announcement regarding next major steps regarding AMDX in the near future. LymPro very much alive "....
On the "Shortly to SOON Scale...." Shortly being 1, is "near future" a 5 or more ike an 8?, Where SOON is a 10. I understand his message, just trying to get a calibration. For example, I read a "shortly" to be , any day now....and "soon' is ...sometime in my lifetime.
Not that long ago liars were considered to be the worst kind of personal failure. We make our investment deceisions based on DD, various facts including financial along with what we derive from PR . In the end we balance evrything to decide any action. There are a lot of smart people here(not that I am qualified to judge) who decided to support AMBS as an investment. The world class BOD, the integrity of the WW medical research community, anaecdotes such BD assay results, papers on MANF, patents do not get granted irresponsibily....and anaecdotes... "we will never uplist from weakness". I hope the country gets back to isolateing and scorning liars, we must watch and profile liars, track them like child abusers. The country is full of liars now, some are running the government but most of us keep our lives private and avoid associating with known liars. We need to get back to that, liars hurt everyone, GC needs to be marked.
On behalf of all patients who may/will benefit and those of us wanting to retire (next 30 mis would be fine but I can wait till Tuesday) we all hope you are right and that this is just the start...building to $200 buyout.
I like the fact that NVIV acts like it belongs in the room and expects to be heard. That disposition is consistent with the path this device and technology is taking.